Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Working Knowledge
Business Research for Business Leaders
  • Browse All Articles
  • Popular Articles
  • Cold Call Podcasts
  • About Us
  • Leadership
  • Marketing
  • Finance
  • Management
  • Entrepreneurship
  • All Topics...
  • Topics
    • COVID-19
    • Entrepreneurship
    • Finance
    • Gender
    • Globalization
    • Leadership
    • Management
    • Negotiation
    • Social Enterprise
    • Strategy
  • Sections
    • Book
    • Cold Call Podcast
    • HBS Case
    • In Practice
    • Lessons from the Classroom
    • Op-Ed
    • Research & Ideas
    • Research Event
    • Sharpening Your Skills
    • What Do You Think?
    • Working Paper Summaries
  • Browse All
    • COVID-19 Business Impact Center
      COVID-19 Business Impact Center
      Cold Call
      A podcast featuring faculty discussing cases they've written and the lessons they impart.
      Subscribe on iTunes
      • 19 Jan 2021
      • Cold Call Podcast

      Engaging Community to Create Proactive, Equitable Public Safety

      Saint Paul, Minnesota Mayor Melvin Carter swept into office in 2018 promising equity. He wanted a new public safety framework that would be rooted in community. Then, with the COVID-19 pandemic wiping out much of the city’s budget and the May 2020 killing of George Floyd by a police officer in neighboring Minneapolis sparking calls to defund the police, how would Mayor Carter make these changes happen? Professor Mitch Weiss discusses the challenges and rewards of “possibility government” in his case, "Community-First Public Safety."  Open for comment; 0 Comment(s) posted.

      Read the Transcript

      Filter Results: (53) Arrow Down
      Filter Results: (53) Arrow Down Arrow Up
      • Popular
      • Browse All Articles
      • About Us
      • Newsletter Sign-Up
      • RSS
      • Popular
      • Browse All Articles
      • About Us
      • Newsletter Sign-Up
      • RSS

      Research and DevelopmentRemove Research and Development →

      Page 1 of 53 Results →
      • 30 Nov 2020
      • Working Paper Summaries

      Short-Termism, Shareholder Payouts, and Investment in the EU

      by Jesse M. Fried and Charles C.Y. Wang

      Shareholder-driven “short-termism,” as evidenced by increasing payouts to shareholders, is said to impede long-term investment in EU public firms. But a deep dive into the data reveals a different story.

      • 24 Aug 2020
      • Working Paper Summaries

      When Do Experts Listen to Other Experts? The Role of Negative Information in Expert Evaluations for Novel Projects

      by Jacqueline N. Lane, Misha Teplitskiy, Gary Gray, Hardeep Ranu, Michael Menietti, Eva C. Guinan, and Karim R. Lakhani

      Evaluators of early-stage scientific proposals tend to systematically focus on the weaknesses of proposed work rather than its strengths, according to evidence from two field experiments.

      • 10 Aug 2020
      • Research & Ideas

      COVID's Surprising Toll on Careers of Women Scientists

      by Rachel Layne

      Women scientists and those with young children are paying a steep career price in the pandemic, according to new research by Karim Lakhani, Kyle Myers, and colleagues. Open for comment; Comment(s) posted.

      • 02 Aug 2020
      • What Do You Think?

      Is the 'Experimentation Organization' Becoming the Competitive Gold Standard?

      by James Heskett

      SUMMING UP: Digital experimentation is gaining momentum as an everyday habit in many organizations, especially those in high tech, say James Heskett's readers. Open for comment; Comment(s) posted.

      • 08 Jul 2020
      • Working Paper Summaries

      Inventing the Endless Frontier: The Effects of the World War II Research Effort on Post-War Innovation

      by Daniel P. Gross and Bhaven N. Sampat

      Investments made in World War II by the United States Office of Scientific Research and Development powered decades of subsequent innovation and the take-off of regional technology hubs around the country.

      • 23 Mar 2020
      • Working Paper Summaries

      The Effects of Hierarchy on Learning and Performance in Business Experimentation

      by Sourobh Ghosh, Stefan H. Thomke, and Hazjier Pourkhalkhali

      Do senior managers help or hurt business experiments? Analyzing a dataset of more than 6,300 experiments on the A/B/n testing platform Optimizely, this study suggests that involving senior executives in experimentation teams can have surprising consequences.

      • 04 Dec 2019
      • Book

      Creating the Experimentation Organization

      by Michael Blanding

      New tools allow companies to innovate on an unprecedented scale, in every aspect of business. But the organization must also change. Stefan Thomke previews his forthcoming book, Experimentation Works. Open for comment; Comment(s) posted.

      • 12 Nov 2019
      • Research & Ideas

      Corporate Innovation Increasingly Benefits from Government Research

      by Michael Blanding

      Nearly a third of US patents rely directly on government-funded research, says Dennis Yao. Is government too involved in supporting private sector innovation—or not enough? Open for comment; Comment(s) posted.

      • 28 Feb 2019
      • Cold Call Podcast

      Pursuing Precision Medicine at Intermountain Healthcare

      Re: Richard G. Hamermesh

      What happens when Intermountain Healthcare invests resources in an innovative precision medicine unit to provide life-extending, genetically targeted therapies to late-stage cancer patients? Professors Richard Hamermesh and Kathy Giusti discuss the case and its connections to their work with the Kraft Precision Medicine Accelerator. Open for comment; Comment(s) posted.

      • 19 Dec 2018
      • Working Paper Summaries

      Find and Replace: R&D Investment Following the Erosion of Existing Products

      by Joshua Krieger, Xuelin Li, and Richard T. Thakor

      This study sheds light on how product outcomes shape the direction of innovation and markets for technology. In the drug development industry in particular, negative product shocks appear to spur investment changes both within the directly affected firm and in competing firms in the same R&D markets.

      • 04 Oct 2018
      • Working Paper Summaries

      Corruption, Government Subsidies, and Innovation: Evidence from China

      by Lily Fang, Josh Lerner, Chaopeng Wu, and Qi Zhang

      Governments subsidize a growing number of innovation efforts, many of which may face the challenge of corruption. Using Chinese data, this study finds corruption-related distortions in government R&D subsidies, which diminished after the 2012 anti-corruption campaign and rotation of provincial officials. It provide insights for designing effective R&D subsidy programs.

      • 09 Feb 2018
      • Working Paper Summaries

      Developing Novel Drugs

      by Joshua Krieger, Danielle Li, and Dimitris Papanikolaou

      This paper contributes to our understanding of how financing constraints affect the direction of innovation in drug development. The authors develop a new measure of drug novelty based on molecular characteristics, and explore the tradeoffs involved in decisions to develop more novel therapies. Open for comment; Comment(s) posted.

      • 15 Jan 2018
      • Research & Ideas

      A Better Business Model for Fighting Cancer

      by Julia Hanna

      The Kraft Precision Medicine Accelerator aims to speed up the development and delivery of cancer therapies by improving the business processes that surround them. Open for comment; Comment(s) posted.

      • 26 Jul 2016
      • Working Paper Summaries

      The Impact of the Entry of Biosimilars: Evidence from Europe

      by Fiona Scott Morton, Ariel Dora Stern, and Scott Stern

      Biosimilars are large-molecule drugs that, while not an exact copy of already-approved large-molecule drugs, have been shown to be therapeutically equivalent. Much like generic drugs, which become available when a small-molecule drug goes off patent, biosimilars are lower in cost than their reference products and present an opportunity for savings when large-molecule drugs’ patents expire. Biosimilars have been available in the United States only since 2015 but have been regulated, approved, and sold in Europe for over a decade. This paper examines the European experience to help inform policy design and institutional choices for the United States. Topics covered include the entry of distributors and unique products; predictors of average product prices following biosimilar competition; and penetration of biosimilars as a share of total sales.

      • 10 Aug 2015
      • Research & Ideas

      New Medical Devices Get To Patients Too Slowly

      by Michael Blanding

      The FDA has streamlined drug testing to ensure new therapies come to market quickly. But when it comes to life-giving medical devices, approvals seem unnecessarily slow, according to research by Ariel Dora Stern. Open for comment; 6 Comment(s) posted.

      • 01 Dec 2014
      • Working Paper Summaries

      Financing Innovation

      by William R. Kerr & Ramana Nanda

      There is growing consensus that well-functioning financial markets play a central role in driving economic growth through their ability to spur technological innovation. In this paper for the Annual Review of Financial Economics, the authors ask how financial markets might actively shape the nature of R&D that is undertaken. They also examine how this may impact technological innovation and growth through the shaping of the ideas that are developed across firms. Drawing on a new but growing literature on the role that capital markets and financial intermediaries play in impacting firm-level innovation, the authors first elaborate on theoretical contributions regarding why financing R&D projects might be distinct from financing other types of projects and the channels through which financial intermediaries and capital markets can impact innovation. They then discuss empirical studies on financing innovation in mature firms, in particular the literature on how ownership and capital structure impact the amount and nature of innovation undertaken by firms. The paper also looks at innovation in startups and the growing literature on the effect that multi-stage financing has on innovation in young firms. Three main themes emerge: 1) A growing body of work documents a role for debt financing related to innovation. 2) A very active area of research has looked at "learning" across multi-stage financing. 3) There is strong interaction between financing choices for innovation and changing external conditions. Key concepts include: Financing constraints can be extensive in the context of firms engaged in R&D and innovation-with the ability to shape both the rate and the trajectory of innovation. Capital structure plays a central role in the outcome of innovations. Bank finance is an important source of finance, particularly for larger firms with tangible and intangible assets to pledge as collateral. Public markets may provide deep pockets but pose a set of agency costs that might be particularly harmful for firms engaged in exploration and novel innovations. There is a growing interest among academics and practitioners in the multi-stage financing of innovation, both in established firms and startups, and understanding the optimal contracts and policies that might stimulate innovation. Closed for comment; 0 Comment(s) posted.

      • 31 Jul 2014
      • Research & Ideas

      A Scholarly Crowd Explores Crowdsourcing

      by Sean Silverthorne

      At the Open and User Innovation Workshop, several hundred researchers discussed their work on innovation contests, user-led product improvements, and the biases of crowds. Closed for comment; 1 Comment(s) posted.

      • 23 Jul 2014
      • Lessons from the Classroom

      Innovation Is Magic. Really

      by Dina Gerdeman

      When Stefan Thomke teaches students how to manage innovation and creativity, he turns to an unexpected source: Magician Jason Randal. Open for comment; 12 Comment(s) posted.

      • 14 Jul 2014
      • Research & Ideas

      Pay Attention To Your ‘Extreme Consumers’

      by Michael Blanding

      Jill Avery and Michael Norton explain what marketers can learn from consumers whose preferences lie outside of the mainstream. Open for comment; 5 Comment(s) posted.

      • 19 Sep 2013
      • Working Paper Summaries

      U.S. High-Skilled Immigration, Innovation, and Entrepreneurship: Empirical Approaches and Evidence

      by William R. Kerr

      In the 2008 Current Population Survey, immigrants represented 16 percent of the United States workforce with a bachelor's education. Moreover, immigrants accounted for 29 percent of the growth in this workforce during the 1995-2008 period. Exceeding these strong overall contributions, the role of immigrants within science, technology, engineering, and mathematics (STEM) fields is even more pronounced. Even so, the importance of the global migration of STEM talent has been under-studied. In this paper, which focuses exclusively on the United States' experience, the author reviews academic work regarding the effects of global migration on innovation and entrepreneurship. Findings show that while some aspects of the phenomenon are well understood, such as the quantity and quality of immigrants, scholars still have very little insight on others, such as return migration. Overall, immigration has clearly been essential for the United States' leadership in innovation and entrepreneurship. There is also evidence of positive impacts of high-skilled diasporas for home countries, although the ledger that can be measured in the United States remains incomplete. Key concepts include: Scholars are just beginning to trace out and quantify how the economy reacts to immigration. Academic research on low-skilled immigration has a longer history, and efforts to evaluate high-skilled immigration are just starting to define its unique attributes from general immigration (e.g., the impact of firm sponsorship of H-1B visas). In terms of quantity, immigrants generally account for about a quarter of the US workforce engaged in science, technology, engineering, and mathematics (STEM) fields. This share is growing rapidly. In terms of quality, most immigrants engaged in STEM work in the United States are better trained for this work than natives (e.g., chosen academic fields of study, levels of education obtained). Conditional on these education choices, immigrants and natives appear quite comparable in quality, with some greater potential for the "long tail" of superstars. Immigration is associated with higher levels of innovation for the United States. The short-run consequences for natives are minimal. However, this aggregate achievement involves some displacement of U.S. workers, and the long-run impact is less understood. Long-run estimates range from very positive to substantial crowding-out depending upon the study and technique. High-skilled immigrants promote knowledge flows and foreign direct investments to their home countries. It is still unclear whether this benefit fully compensates the country for the potential negative consequences from the talent migration. Closed for comment; 0 Comment(s) posted.

      • 1
      • 2
      • 3
      • →
      ǁ
      Campus Map
      Harvard Business School Working Knowledge
      Baker Library | Bloomberg Center
      Soldiers Field
      Boston, MA 02163
      Email: Editor-in-Chief
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College